首页> 美国卫生研究院文献>Frontiers in Genetics >Validation of a multiplex reverse transcription and pre-amplification method using TaqMan® MicroRNA assays
【2h】

Validation of a multiplex reverse transcription and pre-amplification method using TaqMan® MicroRNA assays

机译:使用TaqMan®MicroRNA分析验证多重逆转录和预扩增方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since the discovery of microRNAs (miRNAs), different approaches have been developed to label, amplify and quantify miRNAs. The TaqMan® technology, provided by Applied Biosystems (ABIs), uses a stem-loop reverse transcription primer system to reverse transcribe the RNA and amplify the cDNA. This method is widely used to identify global differences between the expression of 100s of miRNAs across comparative samples. This technique also allows the quantification of the expression of targeted miRNAs to validate observations determined by whole-genome screening or to analyze few specific miRNAs on a large number of samples. Here, we describe the validation of a method published by ABIs on their web site allowing to reverse transcribe and pre-amplify multiple miRNAs and snoRNAs simultaneously. The validation of this protocol was performed on human muscle and plasma samples. Fast and cost efficient, this method achieves an easy and convenient way to screen a relatively large number of miRNAs in parallel.
机译:自发现microRNA(miRNA)以来,已开发出多种方法来标记,扩增和定量miRNA。 Applied Biosystems(ABIs)提供的TaqMan ®技术使用茎环逆转录引物系统逆转录RNA并扩增cDNA。该方法被广泛用于鉴定比较样品中100多种miRNA表达之间的总体差异。这项技术还可以对靶向miRNA的表达进行定量,以验证通过全基因组筛选确定的观察结果,或分析大量样品上少量的特定miRNA。在这里,我们描述了ABI在其网站上发布的方法的验证,该方法允许同时逆转录和预扩增多个miRNA和snoRNA。该协议的验证是在人体肌肉和血浆样品上进行的。快速且经济高效,该方法实现了一种简便快捷的并行筛选相对大量miRNA的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号